Nabriva Therapeutics (NASDAQ:NBRV) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Shares of NBRV opened at $0.01 on Wednesday. The firm has a market cap of $320,150.00, a PE ratio […]
StockNews.com began coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Shares of NBRV opened at $0.01 on Wednesday. The firm has a market cap of $320,150.00, a PE ratio […]
